Are you an experienced research scientist looking to lead an exciting genomics project using the most flexible automation platform on the market? Keep reading.
Genome editing is at the forefront of biomedical research, with technologies like CRISPR-Cas9 revolutionising our approach to understanding and treating genetic disorders. At the cutting edge of this field is The Francis Crick Institute (The Crick), a beacon of research and innovation in the UK.
However, the ambitions of genome editing are often bottlenecked by the limitations of manual laboratory processes. Enter lab automation – a transformative approach that enhances precision, efficiency, and reproducibility.
Automata has been partnering with the Advanced Sequencing Facility (ASF) at The Crick to automate many of their workflows – currently 5 workflows and counting.
The ASF’s workflows are being automated using Automata’s LINQ platform, a combined software and hardware solution that digitally and robotically connects workflows end to end, removing manual interventions meaning the scientists at the facility have more time to analyse, discover and innovate.
The Crick is now looking for a Senior Laboratory Scientist to work at the ASF on a unique project at the intersection of assay development and automation. The deadline for applications is Sunday 19 November 23:59 GMT.
This UKRI-funded project is a collaboration between the ASF, the Crick Genetic Modification Service (GeMS) and Automata. The successful candidate will be leveraging the automation capabilities of Automata’s integrated LINQ platform to develop a robust and efficient assay for the genetic characterisation of genetically modified embryos in GeMS.
The post will be based at the Advanced Sequencing Facility as part of a team of 17 scientists who provide Next Generation Sequencing (NGS) support to research groups at The Crick, and the successful candidate will also receive support from Automata’s scientists and engineers.
The funding for this position comes from a new funding mechanism, supported by The Medical Research Council (MRC-UKRI), specifically designed to support collaborations with Small to Medium-sized Enterprises (SMEs). The ASF and Automata submitted a joint application that successfully secured funding, representing The Crick’s inspiring commitment to a future where scientific innovation is accelerated, and new treatments are brought to the public sphere faster using automation.
The United Kingdom Research and Innovation (UKRI) is a key player in propelling such scientific endeavours forward and we thank UKRI and the MRC for their continued investment in projects that promote automation technologies and the benefits they can have on life sciences in the UK.
To find out more about the role and to apply, visit The Francis Crick Institute website.
Watch Francis Crick Institute’s Jérôme Nicod discusses the impact of automating genomic…
Read more On-demand webinar: Thinking beyond the benchtop instruments
Automata partners with The Francis Crick Institute on integrated automation for genomics…
Read more Automata partners with The Francis Crick Institute